Losartan potassium and hydrochlorothiazide tablets
Reason category: Sterility / contamination
FDA recall number D-0498-2024
Blood pressure
Losartan 50 mg tablet
Public data on losartan from CMS and FDA: what pharmacies have paid for it, how many generic applications FDA has approved, and whether it appears in FDA's shortage or recall records.
$0.0332
NADAC per ea (2026-11)
approximate acquisition cost, not a retail price
-51%
change over five years
peak $0.1233 in 2020-09
25
approved generic applications (ANDAs) on record for Losartan Potassium
16 with a product still marketed · first 2010
Not listed
in FDA's current shortage list
no matching FDA shortage entries
NADAC per unit, monthly
LOSARTAN POTASSIUM 50 MG TABShow as table
| Month | NADAC per unit ($) |
|---|---|
| 2013-11 | 0.06901 |
| 2014-02 | 0.07989 |
| 2014-05 | 0.06913 |
| 2014-08 | 0.06617 |
| 2014-11 | 0.06691 |
| 2015-02 | 0.06445 |
| 2015-05 | 0.05995 |
| 2015-08 | 0.05644 |
| 2015-11 | 0.05017 |
| 2016-02 | 0.05249 |
| 2016-05 | 0.05242 |
| 2016-08 | 0.04953 |
| 2016-11 | 0.04768 |
| 2017-02 | 0.04300 |
| 2017-05 | 0.04063 |
| 2017-08 | 0.04040 |
| 2017-11 | 0.03897 |
| 2018-02 | 0.03771 |
| 2018-05 | 0.03618 |
| 2018-08 | 0.03428 |
| 2018-11 | 0.03375 |
| 2019-02 | 0.03717 |
| 2019-05 | 0.03956 |
| 2019-08 | 0.05214 |
| 2019-11 | 0.06918 |
| 2020-02 | 0.09899 |
| 2020-05 | 0.11422 |
| 2020-08 | 0.11736 |
| 2020-11 | 0.10791 |
| 2021-02 | 0.09099 |
| 2021-05 | 0.08688 |
| 2021-08 | 0.08272 |
| 2021-11 | 0.06817 |
| 2022-02 | 0.06868 |
| 2022-05 | 0.06858 |
| 2022-08 | 0.05825 |
| 2022-11 | 0.06207 |
| 2023-02 | 0.05233 |
| 2023-05 | 0.04335 |
| 2023-08 | 0.04532 |
| 2023-11 | 0.04293 |
| 2024-02 | 0.04052 |
| 2024-05 | 0.03791 |
| 2024-08 | 0.04047 |
| 2024-11 | 0.03595 |
| 2025-02 | 0.03688 |
| 2025-05 | 0.03739 |
| 2025-08 | 0.03481 |
| 2025-11 | 0.03057 |
| 2026-02 | 0.03163 |
| 2026-05 | 0.03388 |
| 2026-08 | 0.03285 |
| 2026-11 | 0.03316 |
Source: CMS NADAC weekly files, generic rows, monthly median of weekly averages · data as of 2026-11. Figures can change and may contain errors in the source data. Check the original source before relying on them.
Recall records mentioning losartan
openFDA enforcement records, by year reported.
| 2024 | 1 |
| 2023 | 1 |
| 2022 | 30 |
| 2021 | 1 |
| 2020 | 9 |
| 2019 | 62 |
| 2018 | 1 |
| 2015 | 4 |
| 2014 | 8 |
117 records since 2012. A record is one product or lot, not one recall event. Combination products that contain losartan are included.
What these numbers mean
NADAC is what retail pharmacies pay on average to buy the drug, published by CMS. It does not include rebates and is not what you pay at the counter. ANDA counts include all strengths and forms and applications whose products are now discontinued.
Most recent recall records
Losartan potassium tablets
Reason category: Sterility / contamination
FDA recall number D-0895-2023
Losartan potassium tablets
Reason category: Impurities (e.g. nitrosamines)
FDA recall number D-1161-2022
Losartan potassium tablets
Reason category: Impurities (e.g. nitrosamines)
FDA recall number D-1162-2022
Losartan potassium tablets
Reason category: Impurities (e.g. nitrosamines)
FDA recall number D-1163-2022
Not health advice. GxRadar is for general information only. Nothing here is medical, pharmacy, legal or financial advice. Do not start, stop or change any medicine based on this site. Talk to your pharmacist or prescriber about your own situation.
Articles that mention losartan
17 GxRadar articles cite or discuss this drug.
Case histories · Data story · 5 min
The valsartan recall and what it did to prices
After FDA's July 2018 valsartan recalls, the national average cost of a 160 mg tablet rose from 9.5 cents to 37 cents in five months. Eight years later it is still above its pre-recall level.
Price histories · Data story · 5 min
What pharmacies pay for seven blood pressure generics, 2014 and 2026
At federal survey rates, 365 tablets each of seven common blood pressure generics cost pharmacies about $95 in October 2026, down from $1,403 in October 2014. One drug explains most of the drop.
Case histories · History · 6 min
How a carcinogen in blood pressure pills changed generic drug testing
Since 2018, nitrosamine impurities have produced nearly 500 federal recall records, pushed ranitidine off the US market and led FDA to set daily intake limits for impurities formed from the drug itself.
Price histories · Data story · 5 min
What pharmacies pay for a month of common generics
Thirty tablets of each of the 10 most-used generics we track cost pharmacies $35.70 in January 2014 and $8.80 in October 2026. That is acquisition cost, and the rest of the price sits on top of it.
Recall data · Data story · 6 min
The reasons drugs get recalled, counted from FDA's own records
A GxRadar count of 18,076 FDA drug recall records since 2012 shows a handful of failure types, led by sterility, manufacturing lapses, impurities and pills that dissolve out of spec.
How recalls work · How-to guide · 6 min
How to read an FDA recall notice
A field-by-field reading of a real October 2026 Enforcement Report entry, what the recall classes and statuses mean, and how to check whether your own medicine comes from a recalled lot.